miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
Cuiping Liu,1 Yizhou Jiang,2 Baosan Han3 1Department of Breast Surgery, Affiliated Hospital of Chifeng University, Chifeng, Inner Mongolia 024005, People’s Republic of China; 2Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republi...
Main Authors: | Liu C, Jiang Y, Han B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/mir-613-suppresses-chemoresistance-and-stemness-in-triple-negative-bre-peer-reviewed-article-CMAR |
Similar Items
-
FAM225A facilitates colorectal cancer progression by sponging miR‐613 to regulate NOTCH3
by: Xuexiu Zhang, et al.
Published: (2020-06-01) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
by: Sarah Richtmann, et al.
Published: (2019-05-01) -
LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
by: Wenyi Wang, et al.
Published: (2021-05-01) -
Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
by: Young Hwa Soung, et al.
Published: (2020-08-01) -
FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway
by: Li Rong, et al.
Published: (2020-12-01)